Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0345904
Disease: Malignant neoplasm of liver
Malignant neoplasm of liver
0.550 AlteredExpression disease BEFREE Considering the possibility that MYC may amplify the expression of PPARA target genes to potentiate cell proliferation and liver cancer, gene expression was analyzed from livers of wild-type and liver-specific Myc knockout (Myc<sup>ΔHep</sup> ) mice treated with the PPARA agonist pirinixic acid. 30697791 2019
CUI: C0345904
Disease: Malignant neoplasm of liver
Malignant neoplasm of liver
0.550 Biomarker disease CTD_human We also found higher PPARα expression in the tumor area than adjacent areas and subsequently compared PPARα expression in four different hepatic cancer cell lines. 29134746 2018
CUI: C0345904
Disease: Malignant neoplasm of liver
Malignant neoplasm of liver
0.550 Biomarker disease BEFREE In addition, a number of concurrent molecular and cellular events have been classified as modulating factors, because they potentially alter the ability of PPARα activators to increase rodent liver cancer while not being key events themselves. 29197930 2018
CUI: C0345904
Disease: Malignant neoplasm of liver
Malignant neoplasm of liver
0.550 Biomarker disease BEFREE Activation of mouse, but not human, PPARα induces hepatocellular proliferation, hepatomegaly, and liver cancer. 25991671 2015
CUI: C0345904
Disease: Malignant neoplasm of liver
Malignant neoplasm of liver
0.550 Biomarker disease BEFREE There have been no reports, however, demonstrating that PPARα is involved in the development of human liver cancer. 22168458 2011
CUI: C0345904
Disease: Malignant neoplasm of liver
Malignant neoplasm of liver
0.550 Biomarker disease CTD_human Impact of environmental chemicals on key transcription regulators and correlation to toxicity end points within EPA's ToxCast program. 20143881 2010
CUI: C0345904
Disease: Malignant neoplasm of liver
Malignant neoplasm of liver
0.550 SusceptibilityMutation disease RGD PPAR-alpha L162V polymorphism in human hepatocellular carcinoma. 19119483 2008
CUI: C0345904
Disease: Malignant neoplasm of liver
Malignant neoplasm of liver
0.550 Biomarker disease BEFREE Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences. 9924174 1999